Unraveling the role of LncRNAs in glioblastoma progression: insights into signaling pathways and therapeutic potential

Glioblastoma (GBM) is one of the most aggressive types of brain cancer, characterized by its poor prognosis and low survival rate despite current treatment modalities. Because GBM is lethal, clarifying the pathogenesis’s underlying mechanisms is important, which are still poorly understood. Recent d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Metabolic brain disease 2024-11, Vol.40 (1), p.42, Article 42
Hauptverfasser:	Doghish, Ahmed S., Abd-Elmawla, Mai A., Hatawsh, Abdulrahman, Zaki, Mohamed Bakr, Aborehab, Nora M., Radwan, Abdullah F., Moussa, Rewan, Eisa, Mahmoud A., Mageed, Sherif S. Abdel, Mohammed, Osama A., Abdel-Reheim, Mustafa Ahmed, Elimam, Hanan
Format:	Artikel
Sprache:	eng
Schlagworte:	1-Phosphatidylinositol 3-kinase AKT protein Animals Biochemistry Biomarkers Biomedical and Life Sciences Biomedicine Blood-brain barrier Brain Neoplasms - drug therapy Brain Neoplasms - genetics Brain Neoplasms - metabolism Brain Neoplasms - therapy Cancer Disease Progression Epigenetics Gene Expression Regulation, Neoplastic Genetics Glioblastoma Glioblastoma - drug therapy Glioblastoma - genetics Glioblastoma - metabolism Glioblastoma - therapy Glioma Humans Malignancy Medical prognosis Metabolic Diseases Neurology Neurosciences Non-coding RNA Nucleotides Oncology p53 Protein Pathogenesis Review RNA, Long Noncoding - genetics RNA, Long Noncoding - metabolism Signal Transduction Wnt protein β-Catenin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!